Feature image

What's New

Have your say – Medsafe consultation

Medsafe is seeking comments on proposed changes to current warning and advisory statements for paracetamol.

Go to consultation

News and Events

Date Type Title
18/11/2019Monitoring CommunicationM² Logo Possible risk of vasculitis with dabigatran (Pradaxa)
12/11/2019Monitoring CommunicationUpdate 7 November 2019 - Breast Implants and anaplastic large cell lymphoma
12/11/2019Monitoring CommunicationSuspected adverse reaction reports to lamotrigine after changing brands
7/11/2019Monitoring CommunicationEveret (levetiracetam) - supply and potential seizure control issues for patients
6/11/2019Alert CommunicationConsumer level recall of one lot of Avonex Pen 30mcg in 0.5mL, Lot 1422362
4/11/2019ConsultationConsultation on proposed changes to current warning and advisory statements for paracetamol
25/10/2019CommitteesMinutes of the 179th Medicines Adverse Reactions Committee Meeting
21/10/2019Monitoring CommunicationReview of chemically synthesised active pharmaceutical ingredients for presence of nitrosamine impurity
21/10/2019Alert CommunicationMedicines containing ranitidine and a potential impurity, N-nitrosodimethylamine (NDMA)
21/10/2019Monitoring CommunicationLosartan approved medicines supplied in New Zealand not affected by recalls overseas
16/10/2019CommitteesAgenda for the 108th meeting of the Medicines Assessment Advisory Committee - 13 November 2019
14/10/2019MedicinesPart 2: Obtaining approval for new and changed medicines (PDF 1220KB, 65 Pages) and Appendix 8: Data Requirements for New Medicine Applications (PDF 212 KB, 26 pages) have been updated
11/10/2019NoticesMedsafe Office Closure Christmas/New Year 2019/2020
11/10/2019Alert CommunicationMedsafe is issuing a warning that Valentus SlimROAST Optimum Dark Roast Coffee should not be consumed - statement under section 98 of the Medicines Act 1981
11/10/2019Alert CommunicationSurgical Mesh Implants - Adverse Event Reporting and Monitoring - Link to the latests October 2019 report
9/10/2019PublicationsMedical Device Adverse Event Reporting
8/10/2019NoticesNotice of Medsafe Office Closure Christmas/New Year 2019/2020
1/10/2019ConsultationOutcome of consultation on the changes to the prescribing restrictions of riluzole
25/09/2019Dear Healthcare Professional LetterMMR II Vaccine - Additional supply of MMR II measles, mumps and rubella vaccine: differences in labelling and package inserts
23/09/2019Alert CommunicationMedicines containing ranitidine and a potential impurity, N-nitrosodimethylamine (NDMA)
19/09/2019Monitoring CommunicationUpdate - Mē Logo Possible risk of lichen planus or lichenoid drug eruption with zoster (shingles) vaccine or influenza vaccine